Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Acrylic IOL Implanted in Children Offers Biocompatibility
CHARLESTON, SC-A three-piece acrylic IOL implanted in pediatric patients offered good clinical biocompatibility when compared with a historical control group of one-piece polymethylmethacrylate (PMMA) devices, said M. Edward Wilson, MD, Pierre G. Jenkins Professor and Chairman, Storm Eye Institute, Medical University of South Carolina, Charleston.
Related Videos
Related Content
